Immunoglobulin E-dependent active fatal anaphylaxis in mast cell- deficient mice

Journal of Experimental Medicine

Volumn 188, Issue 9, 1998, Pages 1587-1592

  Choi, Il Hwan ^a   Shin, Young Min ^a   Park, Jae Seung ^a   Lee, Moo Sam ^a   Han, Eue Hyeog ^a   Chai, Ok Hee ^a   Im, Shun Young ^b   Ha, Tai You ^a   Lee, Hern Ku ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Chonnam National University   (South Korea)

Author keywords

Immunoglobulin E; Mast cells; Penicillin V; Platelet activating factor; W W(v) mice

Indexed keywords

6 (2 CHLOROPHENYL) 9 [(3,4 DIMETHOXYPHENYL)THIOMETHYLTHIOCARBONYL] 4,7,8,10 TETRAHYDRO 1 METHYLPYRIDO[4',3':4,5]THIENO[3,2 F][1,2,4]TRIAZOLO[4,3 A][1,4]DIAZEPINE; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 4; MONOCLONAL ANTIBODY; PENICILLIN V; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ALLERGY; ANAPHYLAXIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE DEFICIENCY; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0001449013     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.9.1587     Document Type: Article

References (37)

1. Kinet, J.P. 1989. The high affinity receptor for IgE. Curr. Opin. Immunol. 2:499-505.
2. Metzger, H., G. Alcaraz, R. Hohman, J.P. Kinet, V. Pribluda, and R. Quarto. 1986. The receptor with high affinity for immunoglobulin E. Annu. Rev. Immunol. 4:419-470.
3. Ishizaka, T., and K. Ishizaka. 1984. Activation of mast cells for mediator release through IgE receptors. Prog. Allergy. 34: 188-235.
4. Jacoby, W.P., V. Cammarata, S. Findlay, and S. Pincus. 1984. Anaphylaxis in mast cell-deficient mice. J. Investig. Dermatol. 83:302-304.
5. v mice. Int. Arch. Allergy Appl. Immunol. 80:85-94.
6. d genotypes. Exp. Cell Biol. 55:63-68.
7. Takeishi, T., T.R. Martin, I.M. Katona, F.D. Finkelman, and S.J. Galli. 1991. Differences in the expression of the cardiopulmonary alteration associated with anti-immunoglobulin E-induced or active anaphylaxis in mast cell-deficient and normal mice. J. Clin. Invest. 88:598-608.
8. Martin, T.R., A. Ando, T. Takeishi, I.M. Katona, J.M. Drazen, and S.J. Galli. 1993. Mast cells contribute to the changes in heart rate, but not hypotension or death, associated with active anaphylaxis. J. Immunol. 151:367-374.
9. Lee, H.K., H.H. Lee, Y.M. Park, H.J. Park, J.H. Lee, and T.Y. Ha. 1996. Anti-IL-4 antibody inhibits antigen-specific IgE response but fails to prevent chicken gamma globulin-induced active systemic anaphylaxis: evidence for the involvement of IgG antibodies. J. Korean Med. Sci. 11:111-117.
10. Arimura, A., M. Nagata, A. Watanabe, K. Nakamura, M. Takeuchi, and M. Harada. 1990. Production of active and passive anaphylactic shock in the WBB6F1 mouse, a mast cell-deficient strain. Experientia. 46:739-742.
11. Oettgen, H., T.R. Martin, A. Wynshaw-Boris, C. Deng, J.M. Drazen, and P. Leder. 1994. Active anaphylaxis in IgE-deficient mice. Science. 370:367-370.
12. Park, J.S., I.H. Choi, D.G. Lee, S.S. Han, T.Y. Ha, J.H. Lee, W.H. Lee, Y.M. Park, and H.K. Lee. 1997. Anti-IL-4 monoclonal antibody prevents antibiotics-induced active fatal anaphylaxis. J. Immunol. 158:5002-5006.
13. Ohara, J., and W.E. Paul. 1985. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature. 315:333-336.
14. Finkelman, F.D., I.M. Katona, J.F. Urban, J. Holmes, J. Ohara, A.S. Tung, J.G. Sample, and W.E. Paul. 1988. IL-4 is required to generate and sustain in vivo IgE responses. J. Immunol. 141:2335-2341.
15. Sugatani, J., M. Miwa, Y. Komiyama, and T. Murakami. 1993. Quantitative analysis of platelet-activating factor in human plasma: application to patients with liver cirrhosis and disseminated intravascular coagulation. J. Immunol. Methods. 166:251-261.
16. Bligh, E.G., and W.A. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
17. Harvima, R.J., I.T. Harvima, and J.E. Fraki. 1988. Optimization of histamine radioenzymatic assay with purified histamine N-methyltransferase. Clin. Chim. Acta. 171:247-251.
18. Braquet, P., A. Etienne, C. Touvay, R.H. Bourgain, J. Lefort, and B.B. Vargaftig. 1985. Involvement of platelet activating factor in respiratory anaphylaxis, demonstrated by PAF-acether inhibitor BN 52021. Lancet. 1:1501.
19. Vilain, B., V. Lagente, C. Touvay, S. Desquand, J. Rendon, J. Lefort, P. Braquet, and B.B. Vargaftig. 1986. Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021. Pharmacol. Res. Commun. 18(Suppl.):119-126.
20. Hervert, J.M., L. Lespy, and J.P. Maffrand. 1991. Protective effect of SR27417, a novel PAF antagonist, on lethal anaphylactic and endotoxin-induced shock in mice. Eur. J. Pharmacol. 205:271-276.
21. Weiss, M.E., D. Nyhan, Z. Peng, J.C. Horrow, E. Lowenstein, C. Hirshman, and F. Adkinson. 1989. Association of protamine IgE and IgG antibodies with life-threatening reactions to intravenous protamine. N. Engl. J. Med. 320:886-892.
22. Miyajima, I., D. Dombrowicz, T.R. Martin, J.V. Ravetch, J.P. Kinet, and S.J. Galli. 1997. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and FcγRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE-or IgG1-dependent passive anaphylaxis. J. Clin. Invest. 99:901-914.
23. Dombrowicz, D., V. Flamand, I. Miyajima, J.V. Ravetch, S.J. Galli, and J.P. Kinet. 1997. Absence of Fc∈RI α chain results in upregulation of FcγRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc∈RI and FcγRIII for limiting amounts of FcR β and γ chains. J. Clin. Invest. 99:915-925.
24. Ravetch, J.V., and J.P. Kinet. 1991. Fc receptors. Annu. Rev. Immunol. 9:457-492.
25. Camussi, G., G. Bussolono, G. Salvidio, and C. Baglioni. 1987. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. J. Exp. Med. 166:1390-1404.
26. Chignard, M., J.P. Le Couedic, M. Tence, B.B. Vargaftig, and J. Benveniste. 1989. The role of platelet-activating factor in platelet aggregation. Nature. 279:799-800.
27. Choi, I.H., T.Y. Ha, D.G. Lee, J.S. Park, J.H. Lee, Y.M. Park, and H.K. Lee. 1995. Occurrence of disseminated intravascular coagulation (DIC) in active systemic anaphylaxis: role of platelet-activating factor. Clin. Exp. Immunol. 100: 390-394.
28. Im, S.Y., S.J. Han, H.M. Ko, J.H. Choi, S.B. Chun, D.G. Lee, T.Y. Ha, and H.K. Lee. 1997. Involvement of nuclear factor-KB in platelet-activating factor-mediated tumor necrosis factor-α expression. Eur. J. Immunol. 27:2800-2804.
29. Silvers, W.S. 1992. Exercise-induced allergies: the role of histamine release. Ann. Allergy. 68:58-63.
30. Sun, S., M.H. Weil, W. Tang, R.J. Gazmuri, J. Bisera, S.R. Greenberg, and T.B. Kim. 1992. Cardiac anaphylaxis in the Sprague-Dawley rat J. Lab. Clin. Med. 120:589-596.
31. Rieger, A., B. Wang, O. Kilgus, K. Ochiai, D. Mauerer, D. Fodinger, J.P. Kinet, and G. Stingl. 1992. Fc epsilon RI mediates IgE binding to human epidermal Langerhans cells. J. Investig. Dermatol. 99:30S-32S.
32. Bieber, T., H. de la Salle, A. Wollenberg, J. Hakimi, R. Chizzonite, J. Ring, and D.H. de la Salle. 1992. Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc∈RI). J. Exp. Med. 175:1285-1290.
33. Gounni, A.S., B. Lamkhioued, K. Ochiai, Y. Tanaka, E. Delaporte, A. Capron, J.P. Kinet, and M. Capron. 1994. High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature. 367:183-186.
34. Maurer, D., E. Fiebiger, B. Reininger, B. Wolff-Winiski, M.H. Jouvin, O. Kilgus, J.P. Kinet, and G. Stingl. 1994. Expression of functional high affinity immunoglobulin E receptors (Fc∈RI) on monocytes of atopic individuals. J. Exp. Med. 179:745-750.
35. Joseph, M., A.S. Gounni, J.P. Kusnierz, H. Vorng, M. Sarfati, J.P. Kinet, A.B. Tonnel, A. Capron, and M. Capron. 1997. Expression and functions of the high-affinity IgE receptor on human platelets and megakaryocyte precursors. Eur. J. Immunol. 27:2212-2218.
36. de Andres, B., E. Rakasz, M. Hagen, M.L. McCormik, A.L. Mueller, D. Elliot, A. Metwali, M. Sandor, B.E. Britigan, J.V. Weinstock, and R.G. Lynch. 1997. Lack of Fc-epsilon receptors on murine eosinophils: implication for the functional significance of elevated IgE and eosinophils in parasitic infections. Blood. 89:3826-3836.
37. Capron, M., M. Morita, G. Woerly, F. Lengrand, A.S. Gounni, E. Delaporte, and A. Capron. 1997. Differentiation of eosinophils from cord blood cell precursors: kinetics of Fc∈RI and Fc∈RII expression. Int. Arch. Allergy Immunol. 113:48-50.